{"id":"https://openalex.org/W3011961409","doi":"https://doi.org/10.1158/1535-7163.targ-19-c018","title":"Abstract C018: Primary tumor data analysis reveals novel synthetic lethal dependencies between KRAS mutation and the spliceosome","display_name":"Abstract C018: Primary tumor data analysis reveals novel synthetic lethal dependencies between KRAS mutation and the spliceosome","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W3011961409","doi":"https://doi.org/10.1158/1535-7163.targ-19-c018","mag":"3011961409"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-19-c018","doi":"https://doi.org/10.1158/1535-7163.targ-19-c018","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-c018","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003812416","display_name":"Claire E. Repellin","orcid":"https://orcid.org/0000-0002-6552-3318","observed_orcids":["https://orcid.org/0000-0002-6552-3318"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claire E Repellin","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070412094","display_name":"Puja D. Patel","orcid":"https://orcid.org/0000-0002-7595-1340","observed_orcids":["https://orcid.org/0000-0002-7595-1340"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Puja Patel","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103168394","display_name":"Yihui H. Shi","orcid":"https://orcid.org/0000-0002-8014-1457","observed_orcids":["https://orcid.org/0000-0002-8014-1457"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yihui Shi","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068459886","display_name":"Helena Gong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Helena Gong","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068019825","display_name":"Leena H. Shewade","orcid":"https://orcid.org/0000-0003-4316-0891","observed_orcids":["https://orcid.org/0000-0003-4316-0891"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leena Shewade","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038741616","display_name":"Thomas R. Webb","orcid":"https://orcid.org/0000-0001-8000-0825","observed_orcids":["https://orcid.org/0000-0001-8000-0825"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Webb","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085226365","display_name":"Lidia C. Sambucetti","orcid":"https://orcid.org/0000-0001-9686-5444","observed_orcids":["https://orcid.org/0000-0001-9686-5444"]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lidia Sambucetti","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108545002","display_name":"Subarna Sinha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1298353152","display_name":"SRI International","ror":"https://ror.org/05s570m15","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1298353152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Subarna Sinha","raw_affiliation_strings":["SRI International, Menlo Park, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SRI International, Menlo Park, CA","institution_ids":["https://openalex.org/I1298353152"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1298353152"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"12_Supplement","first_page":"C018","last_page":"C018"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.8306000232696533,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.8306000232696533,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.08420000225305557,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.01080000028014183,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9950000047683716},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.8479999899864197},{"id":"https://openalex.org/keywords/spliceosome","display_name":"spliceosome","score":0.7979999780654907},{"id":"https://openalex.org/keywords/sf3b1","display_name":"SF3B1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/srrm2","display_name":"SRRM2","score":0.996999979019165},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/splicing-modulation","display_name":"splicing modulation","score":0.6769999861717224},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.6949999928474426},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.3840000033378601},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.4970000088214874},{"id":"https://openalex.org/keywords/drug-target-identification","display_name":"drug target identification","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9125404357910156},{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.8072841763496399},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.6234236359596252},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6220760345458984},{"id":"https://openalex.org/C40000846","wikidata":"https://www.wikidata.org/wiki/Q915868","display_name":"Spliceosome","level":5,"score":0.5633012652397156},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.5261249542236328},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5232542753219604},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5082656741142273},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.4871825575828552},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4696950912475586},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4552255868911743},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.42671677470207214},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3589729964733124},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.33388128876686096},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.17800822854042053},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.08656945824623108},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-19-c018","doi":"https://doi.org/10.1158/1535-7163.targ-19-c018","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-c018","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3179634283","https://openalex.org/W2571525517","https://openalex.org/W2400129688","https://openalex.org/W2886947542","https://openalex.org/W2540786358","https://openalex.org/W2618439945","https://openalex.org/W4296564689","https://openalex.org/W2954789350","https://openalex.org/W4409833901","https://openalex.org/W2811129858"],"abstract_inverted_index":{"Abstract":[0],"Identification":[1],"of":[2,96,102,109,115,141,207,281,294,300,321,326,349,353,455,526],"mutation-specific":[3],"targeted":[4],"therapies":[5],"is":[6,56,111,172,452],"a":[7,49,72,116,163,240,252,279,371,453],"critical":[8],"challenge":[9],"in":[10,35,42,99,125,144,153,194,243,278,381,383,424],"precision":[11],"medicine.":[12],"Synthetic":[13,77],"lethality":[14],"provides":[15],"the":[16,94,100,130,259,319,401,421,434,521,527],"basis":[17],"for":[18,26,58,167,178,433,473,485],"an":[19,40,382],"approach":[20],"to":[21,31,46,65,136,176,186,239,330,367,370,418,481],"identify":[22,137,187],"new":[23,73,470],"therapeutic":[24,471],"targets":[25,250,461,472],"mutations":[27,143,149,193],"that":[28,80,112,318,359,400,429,449],"are":[29,150,416,430],"difficult":[30],"target":[32],"directly,":[33],"since":[34],"synthetic":[36,459,514],"lethal":[37,460,515],"(SL)":[38],"interactions,":[39],"alteration":[41,53],"one":[43],"gene":[44],"leads":[45],"dependency":[47,277],"on":[48,162,257,298,442,531],"second":[50],"gene.":[51],"Neither":[52],"by":[54,263,388,409,463],"itself":[55],"essential":[57],"survival,":[59],"but":[60,333],"together":[61],"these":[62,208,379],"alterations":[63],"lead":[64,480],"cancer":[66,155,198,426,487],"cell":[67,196,283,314,362,427],"death.":[68],"We":[69,183,316],"previously":[70],"developed":[71],"computational":[74],"method,":[75],"Mining":[76],"Lethals":[78],"(MiSL),":[79],"can":[81,468,479],"infer":[82],"relationships":[83],"from":[84,158],"primary":[85,126,443,464],"human":[86,104],"tumor":[87,127,385,465,509],"genomic":[88],"and":[89,92,156,200,218,229,266,303,308,392,398,520,534],"transcriptomic":[90],"data":[91,161,466,510],"enable":[93,269],"identification":[95],"SL":[97,113,139,188,203,227,422,439],"interactions":[98,189],"context":[101],"native":[103],"tumors.":[105,414,457],"The":[106],"underlying":[107],"assumption":[108],"MiSL":[110,135,185,296],"partners":[114,140],"mutation":[117,519],"will":[118],"be":[119],"selectively":[120],"amplified":[121],"or":[122],"never":[123],"deleted":[124],"samples":[128],"harboring":[129],"mutation.":[131,436],"Here,":[132],"we":[133,236,255,272,290,377],"used":[134],"novel":[138,164,226,513],"KRAS":[142,147,168,181,191,275,306,312,327,335,360,372,390,393,402,412,435,444,456,474,518],"lung":[145,154,197,425],"cancer.":[146],"activating":[148],"highly":[151],"prevalent":[152],"aside":[157],"early":[159],"clinical":[160],"covalent":[165],"inhibitor":[166],"G12C":[169],"mutations,":[170],"there":[171],"no":[173],"reported":[174],"treatment":[175,483],"date":[177],"patients":[179],"with":[180,190,233,346,396],"mutations.":[182],"applied":[184],"G12":[192,445],"non-small":[195],"(NSCLC)":[199],"identified":[201,262,462],"220":[202],"partner":[204],"genes.":[205],"Some":[206],"genes":[209,231],"were":[210,225,364,405],"foreseeable":[211],"dependencies,":[212],"such":[213],"as":[214],"MAPK,":[215],"growth":[216,276,299],"factor":[217],"inflammatory":[219],"signaling":[220],"associated":[221,232],"genes;":[222],"while":[223],"others":[224],"candidates":[228,297],"included":[230],"splicing.":[234],"Since":[235],"have":[237],"access":[238],"splicing-modulating":[241],"drug":[242],"preclinical":[244],"development,":[245],"sudemycin":[246],"D6":[247],"(SD6)":[248],"which":[249,478],"SF3B1,":[251],"spliceosome":[253,522],"subunit,":[254],"focused":[256],"testing":[258],"SF3B1":[260,354],"interactors":[261],"MiSL,":[264],"SLU7":[265,322],"SRRM2.":[267],"To":[268],"validation":[270],"studies,":[271],"first":[273],"verified":[274],"panel":[280],"NSCLC":[282,486],"lines":[284,363,428],"using":[285,355],"siRNA":[286,292,347],"knock-down":[287],"(KD).":[288],"Next,":[289],"tested":[291],"KD":[293,320,348],"predicted":[295],"KRAS-dependent":[301],"(H358":[302],"H441":[304],"\u2013":[305,311],"mutant)":[307],"KRAS-independent":[309],"(H2228":[310],"WT)":[313],"lines.":[315,339],"confirmed":[317],"expression":[323],"reduced":[324],"viability":[325,342],"mutant":[328,361,394,403,446,476],"(75":[329],"85%":[331],"reduced)":[332],"not":[334],"wild-type":[336],"(WT)":[337],"cells":[338],"Similar":[340],"differential":[341],"was":[343],"also":[344,357],"observed":[345],"SF3B1.":[350],"Pharmacological":[351],"inhibition":[352],"SD6":[356,368,397,410],"demonstrated":[358],"more":[365,407],"sensitive":[366],"compared":[369],"WT":[373,391,413],"line":[374],"(>5-30x).":[375],"Finally,":[376,458],"validated":[378],"findings":[380],"vivo":[384],"xenograft":[386],"model":[387],"treating":[389],"tumors":[395,404,447],"showed":[399],"significantly":[406],"inhibited":[408],"than":[411],"Studies":[415],"ongoing":[417],"further":[419],"confirm":[420],"interaction":[423],"isogenic":[431],"except":[432],"In":[437],"conclusion,":[438],"predictions":[440],"based":[441],"indicated":[448],"splicing":[450],"modulation":[451],"vulnerability":[454],"mining":[467],"provide":[469],"specific":[475],"cancers,":[477],"personalized":[482],"options":[484],"patients.":[488],"Citation":[489],"Format:":[490],"Claire":[491],"E":[492],"Repellin,":[493],"Puja":[494],"Patel,":[495],"Yihui":[496],"Shi,":[497],"Helena":[498],"Gong,":[499],"Leena":[500],"Shewade,":[501],"Thomas":[502],"Webb,":[503],"Lidia":[504],"Sambucetti,":[505],"Subarna":[506],"Sinha.":[507],"Primary":[508],"analysis":[511],"reveals":[512],"dependencies":[516],"between":[517],"[abstract].":[523],"In:":[524],"Proceedings":[525],"AACR-NCI-EORTC":[528],"International":[529],"Conference":[530],"Molecular":[532],"Targets":[533],"Cancer":[535,546],"Therapeutics;":[536],"2019":[537],"Oct":[538],"26-30;":[539],"Boston,":[540],"MA.":[541],"Philadelphia":[542],"(PA):":[543],"AACR;":[544],"Mol":[545],"Ther":[547],"2019;18(12":[548],"Suppl):Abstract":[549],"nr":[550],"C018.":[551],"doi:10.1158/1535-7163.TARG-19-C018":[552]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2020-03-23T00:00:00"}